HANGZHOU, China, SHANGHAI and BOSTON, July 8, 2026 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (“Lynk Pharmaceuticals”), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on…
Source: prnewswire
Country: United States